The GLP is committed to full transparency. Download and review our 2019 Annual Report

Biotech leaders worried Trump presidency could spark “brain drain”

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The day following the election of Donald J. Trump as President, a survey of leaders in biotechnology in the United States…showed that Trump’s presidency will negatively impact NIH research funding as well as STEM education….

Over 1,600 professionals, from industry and academia, responded to the survey.

The largest majority, 57.11%, believe that the president-elect will hurt research funding.  24.26% said it would not make a difference, and  9.79% said Trump’s presidency would prove positive.

One respondent expects, however, that industry will seek to outsource R&D to U.S. academic labs: “If done wisely, perhaps there’s a chance such a scheme could augment private funding for life science research.”

“The biotechnology industry faces the possibility of a brain drain, and this is most alarming,” said Mary Ann Liebert, founder and CEO of the 35 year old publication (…”The biotechnology community, like many others, was not prepared for a Trump victory; they must be on high alert to assure that one of this country’s premier enterprises will not be compromised. In general, scientists are not political activists by nature, and this has to change.”

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Biotechnology Leaders Surveyed about Impact of Trump Presidency

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend